Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy

International Journal of Gynecological Pathology

Volumn 28, Issue 2, 2009, Pages 187-192

  Wen, Yong H ^a   Yee, Herman ^a   Goswami, Sunanda ^a   Shukla, Pratibha Sharma ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fascin; Serous ovarian tumors

Indexed keywords

FASCIN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; CYSTADENOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY SEROUS TUMOR; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; MICROFILAMENT PROTEINS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 68949199565     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e318183cfde     Document Type: Article

References (19)

1. Kureishy N, Sapountzi V, Prag S, et al. Fascins and their roles in cell structure and function. Bioessays 2002;24:350-361 (Pubitemid 34305690)
2. Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 2005;37:1787-1804
3. Grothey A, Hashizume R, Sahin AA, et al. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000;83:870-873 (Pubitemid 30707621)
4. Pelosi G, Pastorino U, Pasini F, et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003;88:537-547 (Pubitemid 36363363)
5. Hashimoto Y, Shimada Y, Kawamura J, et al. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004;67:262-270 (Pubitemid 39551711)
6. Cao D, Maitra A, Saavedra JA, et al. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Mod Pathol 2005;18:752-761 (Pubitemid 40780508)
7. Hashimoto Y, Ito T, Inoue H, et al. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005;11:2597-2605 (Pubitemid 40569459)
8. Tong GX, Yee H, Chiriboga L, et al. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol 2005;36:741-746 (Pubitemid 41112028)
9. Roma AA, Prayson RA. Fascin expression in 90 patients with glioblastoma multiforme. Ann Diagn Pathol 2005;9:307-311 (Pubitemid 41676877)
10. Kabukcuoglu S, Ozalp SS, Oner U, et al. Fascin, an actin-bundling protein expression in cervical neoplasms. Eur J Gynaecol Oncol 2005;26:636-641 (Pubitemid 43028059)
11. Xie JJ, Xu LY, Zhang HH, et al. Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 2005;337:355-362
12. Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 2000;78:31-101. (Pubitemid 29498677)
13. Yamashiro S, Yamakita Y, Ono S, et al. Fascin, an actin bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 1998;9:993-1006. (Pubitemid 28457295)
14. Tao YS, Edwards RA, Tubb B, et al. Beta-catenin associates with the actin bundling protein fascin in a noncadherin complex. J Cell Biol 1996;134:1271-1281 (Pubitemid 26300171)
15. Yamaguchi H, Inoue T, Eguchi T, et al. Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 2007;20:552-561 (Pubitemid 46631991)
16. Kabukcuoglu S, Ozalp SS, Oner U, et al. Actin bundling protein fascin expression in ovarian neoplasms: comparison of histopathologic features of tumors obtained by the first and secondary cytoreduction surgeries. Eur J Gynaec Oncol 2006;27:123-128.
17. Hu W, McCrea PD, Deavers M, et al. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000;18:83-88 (Pubitemid 32096054)
18. Grothey A, Hashizume R, Ji H, et al. C-erbB-2/HER-2 upregulates fascin, an actin bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 2000;19:4864-4875 (Pubitemid 30809023)
19. Kurman RJ, Shih IM. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008;27:151-160